Skip to product information
1 of 1
New Year Badge
🏷️ Save up to 70% on all courses, discount auto applied

Washington University School of Medicine in St. Louis 7th Annual IBD Center Multidisciplinary Conference 2025

Washington University School of Medicine in St. Louis 7th Annual IBD Center Multidisciplinary Conference 2025

Regular price $45.00 USD
Regular price Sale price $45.00 USD
Sale Sold out
Girl in a jacket

Instant Download

Your unique download link appears right after you complete your purchase, and is also sent instantly to the email address you provided.

Multi Speciality

Yes

Primary Speciality

Internal-Medicine-Primary-Care

Target Audience

gastroenterologists and multidisciplinary IBD

Content Type

Mixed (Video + PDF)

Size

Mixed (Video + PDF)

Year

Provider/Organization

Other

  • Target Audience: gastroenterologists and multidisciplinary IBD
  • Sample video: contact me for sample video
  • Information:

1. Overview

Course Date: Saturday, March 8, 2025

2. Learning Objectives

Evaluate the optimal positioning of advanced medical therapies, JAK inhibitors, and combination treatments for Crohn’s Disease and Ulcerative Colitis.

Assess novel approaches for refractory IBD, including the potential role of stem cell transplantation and non-formulary agents.

Formulate multidisciplinary management plans for complex presentations, such as stricturing disease and acute severe Ulcerative Colitis.

Integrate adjunctive treatments, including specific dietary protocols, body weight modulation, and mindfulness, into comprehensive IBD care.

Apply updated clinical guidelines for dysplasia screening, scoping practices, and post-operative recurrence prevention in IBD patients.

3. Target Audience

Best for gastroenterologists and multidisciplinary IBD teams who want updates on medical therapies, refractory disease, and diet interventions.

4. Topics

Positioning Medical Therapies in Crohn’s Disease

Debate – Second Line Therapy in Crohns Disease after an Anti-TNF-a – Upadacitinib vs. IL-23

Positioning Medical Therapies in Ulcerative Colitis

Q&A – Using a JAK inhibitor before anti-TNF, Use of Upadacitinib in France vs. U.S.

Novel Approaches to Address Refractory IBD – Stem Cell Transplantation

Breaking the Therapeutic Ceiling in IBD through Innovative Trial Designs

Q&A – Genetic Testing for Stem Cell Transplantation, Minimizing the Risk of Placebo for Patients Entering Clinical Trials…

IBD Case-Based Discussion on Stricturing Disease – Radiologic, Surgical, and Endoscopic Approaches

Debate – Role of JAK inhibitors vs. Surgery in the TNFi-exposed Patient with Acute Severe Ulcerative Colitis

Q&A – Current Recommendations for Prevention of Recurrence of Crohn’s & UC, Role of MR Enterography is post Cro…

Combined Advanced Therapies for IBD – Are We Ready for Prime Time

Nutrition as Therapy for Pediatric IBD

Diet in Adults with IBD

Modulation of Body Weight and Mass as Adjunctive Approaches in IBD Patients

Q&A – Will Kids Actually Drink Elemental Formulas, Safety of GLP-1 in Patients with IBD

Behavioral Approaches Complimentary with Medical Therapies – Mindfulness and IBD

Non-Formulary Agents in Inflammatory Bowel Disease

Approach to Dysplasia in IBD

Q&A – When Do You Stop Scoping Patients, Efficacy of Tacrolimus Suppositories

View full details